Stephen D. Cary,
Mr. Cary is Executive Vice President-Business Development and Chief Operating Officer for Handa Pharmaceuticals, a specialty pharmaceutical company located in the San Francisco Bay area. Prior to joining Handa, Mr. Cary cofounded Cary Pharmaceuticals, where he has served on its Board of Directors since 1994 and as its Executive Vice President-Business Development from June 2000-July 2007. From 1992 to 1999, Mr. Cary was employed as a Professional Sales Representative and Regional Trainer for Glaxo Wellcome Inc. While at Glaxo Wellcome, he successfully promoted products such as Zantac®, Ceftin®, Imitrex® and Zyban® and was a recipient of the company’s President’s Club award for outstanding sales performance.
Mr. Cary earned a Master of Business
Administration from the University of Maryland and a Bachelor of Business
Administration from The University of Iowa. He is the son of Douglas Cary.